Cargando…
Downregulation of RelA (p65) by Rapamycin Inhibits Murine Adipocyte Differentiation and Reduces Fat Mass of C57BL/6J Mice despite High Fat Diet
Rapamycin (RAPA) is a clinical immunosuppressive agent first reported in the literature in 1975 after its discovery in a soil sample from the island of Rapa Nui. Aside from the well-documented effects of RAPA on cell division and immunologic response, the literature reveals it to have negative effec...
Autores principales: | Ray, Peter D., Maclellan, Reid A., He, Jin, Liu, Zhigang, Wu, Jianguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920817/ https://www.ncbi.nlm.nih.gov/pubmed/24587943 http://dx.doi.org/10.1155/2014/540582 |
Ejemplares similares
-
RIP3 is downregulated in human myeloid leukemia cells and modulates apoptosis
and caspase-mediated p65/RelA cleavage
por: Nugues, A-L, et al.
Publicado: (2014) -
Subinhibitory Concentrations of Bacteriostatic Antibiotics Induce relA-Dependent and relA-Independent Tolerance to β-Lactams
por: Kudrin, Pavel, et al.
Publicado: (2017) -
ZBTB2 increases PDK4 expression by transcriptional repression of RelA/p65
por: Kim, Min-Young, et al.
Publicado: (2015) -
Influence of the relA gene on ribosome frameshifting
por: Masucci, J., et al.
Publicado: (2002) -
Identification of genes responsible for RelA-dependent proliferation arrest in human mammary epithelial cells conditionally expressing RelA
por: Kochupurakkal, Bose S., et al.
Publicado: (2015)